Quant-Rho® FITC anti-D (CD240D)

To ensure appropriate anti-D prophylaxis, BCSH Guidelines for the estimation of fetomaternal haemorrhage and AABB Standards recommend confirmation of the volume of the fetal bleed. Quant-Rho® is a FITC-labeled monoclonal anti-D (CD240D) intended for use on a flow cytometer. As an alternative to the Kleihauer-Braun-Betke (KBB) acid elution and anti-HbF flow cytometric methods for quantifying a fetomaternal hemorrhage (FMH). Quant-Rho, similar to the anti-HbF flow cytometric method, offers the advantage of providing more accurate and reproducible results than those obtained from the KBB test. Since it only detects RhD-positive cells, it is particularly useful in patients with high levels of HbF either as a second marker or an alternate approach to anti-HbF staining. The procedure for use is simple and quick, requiring no fixation or permeablization steps- just stain, wash, and run.

Key Benefits

• Quant-Rho is CE marked in compliance with the IVD Directive and has been cleared by the FDA as an IVD for measurement of fetomaternal hemorrhage.
• Detecting only RhD-positive cells makes it useful in distinguishing RhD-negative maternal F-cells from RhD-positive fetal cells.
• Reagent is bottled ready-to-use in 5mL vials (100 tests) and has a 2-yr shelf life.
• Since the D-antigen is a surface antigen, RBC fixation and permeablization is not necessary.
• Compatible with Trillium’s FETALtrol as a system control material.

DOWNLOAD MORE INFORMATION:

BROCHURE (PDF, 196k) PACKAGE INSERT (PDF, 38k)

This product is currently available to Europe and the Middle East through Alba Bioscience, Inc and elsewhere directly from Trillium Diagnostics, LLC.

CONTACT US or use our ORDER FORM for more information.